NYSE: DXDynex Capital Inc Stock
$12.55+0.30 (+2.45%)
Updated Jul 2, 2025
DX Price
$12.55
Fair Value Price
N/A
Market Cap
$1.32B
52 Week Low
$10.79
52 Week High
$14.52
P/E
15.3x
P/B
0.95x
P/S
10.91x
PEG
0.13x
Dividend Yield
10.6%
Revenue
$108.02M
Earnings
$70.70M
Gross Margin
100%
Operating Margin
65.46%
Profit Margin
58.3%
Debt to Equity
5.48
Operating Cash Flow
$38M
Beta
0.69
Next Earnings
Jul 21, 2025
Ex-Dividend
N/A
Next Dividend
N/A
DX Overview
Dynex Capital, Inc., a mortgage real estate investment trust (REIT), invests in mortgage-backed securities (MBS) on a leveraged basis in the U.S. It invests in agency and non-agency MBS consisting of residential MBS, commercial MBS (CMBS), and CMBS interest-only securities. The company was incorporated in 1987 and is headquartered in Glen Allen, VA.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine DX's potential to beat the market
DSell
- Stocks with a Zen Rating of Sell (D) had an average loss of -4.50% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Mortgage REIT
Industry Rating
F
DX
Ranked#36 of 39
Ranked#36 of 39
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $11.68 | C | |
| $6.82 | C | |
| $11.09 | C |
Be the first to know about important DX news, forecast changes, insider trades & much more!
DX News
Overview
Due Diligence Score
–
Industry Average (27)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how DX scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
DX ($12.55) is trading below its intrinsic value of $38.05, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
DX is good value based on its earnings relative to its share price (15.3x), compared to the US market average (31.27x)
P/E vs Market Valuation
DX is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more DX due diligence checks available for Premium users.
Valuation
DX price to earnings (PE)
For valuing profitable companies with steady earnings
Company
15.3x
Industry
3.76x
Market
31.27x
DX is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
DX is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
DX price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.95x
Industry
0.8x
DX is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
DX price to earnings growth (PEG)
For valuing profitable companies with growth potential
DX is good value based... subscribe to Premium to read more.
PEG Value Valuation
DX's financial health
Profit margin
Revenue
$9.0M
Net Income
-$3.1M
Profit Margin
-55.3%
DX's Earnings (EBIT) of $70.70M... subscribe to Premium to read more.
Interest Coverage Financials
DX's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$9.0B
Liabilities
$7.6B
Debt to equity
5.48
DX's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
DX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$6.4M
Investing
-$908.4M
Financing
$868.5M
DX's operating cash flow ($37.86M)... subscribe to Premium to read more.
Debt Coverage Financials
DX vs Mortgage REIT Stocks
Dynex Capital Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.